Recombinant Human CDK9/CycT1 Complex Protein, His/GST-tagged
Cat.No. : | CDK9-1042H |
Product Overview : | Human CDK9, full length, amino acids M1-F372 (as in NCBI/Protein entry NP_001252.1), N- terminal GST-HIS6 fusion protein with a Thrombin cleavage site, and human CycT1, full length, amino acids M1-K726 (as in NCBI/Protein entry NP_001231.2), N-terminal HI |
- Specification
- Gene Information
- Related Products
Source : | Insect cell |
Species : | Human |
Tag : | His/GST |
Molecular Mass : | Theoretical MWGST-CDK9: 72,173 Da Theoretical MWHIS-CycT1: 85,441 Da |
Storage : | At -80 centigrade. For complete recovery, mix well and spin before use. Product must not be stored in diluted solutions, aliquots below 10µl are not advisable. Avoid repeated freeze-thaw cycles! |
Concentration : | 0.168 µg/µl |
Storage Buffer : | 50 mM HEPES pH 7.5, 100 mM NaCl, 5 mM DTT, 4 mM reduced glutathione, 20 % glycerol |
Gene Name : | CDK9 cyclin dependent kinase 9 [ Homo sapiens (human) ] |
Official Symbol : | CDK9 |
Synonyms : | CDK9; cyclin dependent kinase 9; TAK; C-2k; CTK1; CDC2L4; PITALRE; cyclin-dependent kinase 9; CDC2-related kinase; cell division cycle 2-like protein kinase 4; cell division protein kinase 9; serine/threonine protein kinase PITALRE; tat-associated kinase complex catalytic subunit; EC 2.7.11.22; EC 2.7.11.23 |
Gene ID : | 1025 |
mRNA Refseq : | NM_001261 |
Protein Refseq : | NP_001252 |
MIM : | 603251 |
UniProt ID : | P50750 |
Products Types
◆ Recombinant Protein | ||
CDK9-1040H | Recombinant Human CDK9 Protein, GST-Tagged | +Inquiry |
CDK9-967R | Recombinant Rat CDK9 Protein, His (Fc)-Avi-tagged | +Inquiry |
CDK9-617R | Recombinant Rhesus Macaque CDK9 Protein, His (Fc)-Avi-tagged | +Inquiry |
CDK9-11870Z | Recombinant Zebrafish CDK9 | +Inquiry |
CDK9-1309R | Recombinant Rat CDK9 Protein | +Inquiry |
◆ Lysates | ||
CDK9-178HCL | Recombinant Human CDK9 lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionBesides cancer and antiviral therapies, CDK9 is being explored for its role in other diseases, including neurodegenerative disorders.
Yes, combination therapies involving CDK9 inhibitors and other drugs are being investigated to enhance treatment outcomes.
CDK9 expression tends to increase as cancer progresses, suggesting its potential as a biomarker for disease severity.
CDK9 inhibitors can impact normal cell functions, leading to potential side effects such as myelosuppression.
Yes, several clinical trials are exploring the effectiveness of CDK9 inhibitors in different cancer types.
Customer Reviews (3)
Write a reviewIts remarkable quality, versatility, and the manufacturer's commitment to customer satisfaction make it the perfect choice for researchers seeking a premier protein that will undoubtedly enhance their experimental endeavors.
In addition to its remarkable quality and exceptional technical support, the CDK9 Protein boasts an impressive range of applications.
The CDK9 Protein has exceeded my expectations by consistently delivering outstanding results and providing exceptional technical support.
Ask a Question for All CDK9 Products
Required fields are marked with *
My Review for All CDK9 Products
Required fields are marked with *
Inquiry Basket